GENOMEWEB ON DEMAND WEBINAR
SPONSORED BY
FABRIC GENOMICS AND ILLUMINA
New technologies that promise to significantly reduce the cost of sequencing a human genome will have a dramatic impact on healthcare in the next decade. But what are the real benefits of this trend for patients, healthcare systems, and other stakeholders?
As it becomes financially and operationally feasible for everyone to have their genome sequenced, precision medicine will progress rapidly from a largely research-oriented discipline to the clinical setting. By combining whole-genome sequencing with sophisticated artificial intelligence interpretation solutions, applications like personalized treatments for cancer and rare disease, newborn sequencing, polygenic risk scores, pharmacogenomics promise to become the standard of care.
This expert roundtable, moderated by Robert Green of Harvard Medical School, will discuss the range of opportunities that widely accessible whole-genome sequencing presents for precision medicine, as well as the clinical, financial, and operational considerations that clinicians and healthcare systems will need to address in the short and long term. The discussion will be followed by a live Q&A with webinar attendees.
Duration: 1 hour 3 minutes. Originally recorded April 2023. Available on demand.
Robert C. Green, MD, MPH
Professor, Medicine, Harvard Medical School
Geneticist, Medicine, Brigham and Women’s Hospital
Niall J. Lennon, PhD
Senior Director of Translational Genomics at the Broad Institute of MIT and Harvard;
CSO & Chair of the Board of Managers of Broad’s Clinical Testing Laboratory
Alisa Gaskell, PhD
Director, Precision Diagnostics Laboratory
Scientific Director, Children’s Colorado Precision Medicine Institute
Mark Gardner
Senior Vice President, Molecular Genomics and Oncology, Quest Diagnostics
Aleksandar Rajkovic, MD, PhD
Chief Genomics Officer, Professor of Pathology, Medical Director & Chief of the Center for Genetic and Genomic Medicine, University of California, San Francisco Health System
